FAPIX
Price
$12.69
Change
+$0.01 (+0.08%)
Updated
Jun 12 closing price
Net Assets
2.07B
NWEIX
Price
$7.88
Change
+$0.01 (+0.13%)
Updated
Jun 12 closing price
Net Assets
203.6M
Interact to see
Advertisement

FAPIX vs NWEIX

Header iconFAPIX vs NWEIX Comparison
Open Charts FAPIX vs NWEIXBanner chart's image
FAPIX vs NWEIX Comparison Chart in %
View a ticker or compare two or three
VS
FAPIX vs. NWEIX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAPIX is a Hold and NWEIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FAPIX has more cash in the bank: 2.07B vs. NWEIX (204M). NWEIX pays higher dividends than FAPIX: NWEIX (3.89) vs FAPIX (3.24). FAPIX was incepted earlier than NWEIX: FAPIX (6 years) vs NWEIX (19 years). NWEIX (0.46) is less costly to investors than FAPIX (0.05). NWEIX is a more actively managed with annual turnover of: 31.55 vs. FAPIX (19.00). NWEIX has a lower initial minimum investment than FAPIX: NWEIX (1000000) vs FAPIX (2000000000). NWEIX annual gain was more profitable for investors over the last year : 12.20 vs. FAPIX (9.06). FAPIX return over 5 years is better than : 15.89 vs. NWEIX (2.90).
FAPIXNWEIXFAPIX / NWEIX
Total Expense Ratio0.050.4611%
Annual Report Gross Expense Ratio0.050.4611%
Fund Existence6 years19 years-
Gain YTD3.6604.64779%
Front LoadN/AN/A-
Min. Initial Investment20000000001000000200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.07B204M1,013%
Annual Yield % from dividends3.243.8983%
Returns for 1 year9.0612.2074%
Returns for 3 years24.0821.20114%
Returns for 5 years15.892.90548%
Returns for 10 yearsN/A26.99-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TS62.920.94
+1.52%
Tenaris S A
MBAI1.390.02
+1.46%
Check-Cap Ltd.
MMSI66.53-0.36
-0.54%
Merit Medical Systems
ABUS4.26-0.03
-0.70%
Arbutus Biopharma Corp
NYXH1.39-0.10
-6.71%
Nyxoah SA